Yosef Y Tobi (Yosef Tobi)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Tyrosine Kinase

Respiratory Syndrome Coronavirus

Ejection Fraction

Top Venues

International journal of molecular sciences

Nature communications

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Tobi, Martin H Bluth, Noreen F Rossi, Ereny Demian, Harvinder Talwar, Yosef Y Tobi, Paula Sochacki, Edi Levi, Michael Lawson, Benita L McVicker
In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective Population Database? International journal of molecular sciences 24 (8) (2023)
Martin Tobi, Martin H Bluth, Noreen F Rossi, Ereny Demian, Harvinder Talwar, Yosef Y Tobi, Paula Sochacki, Edi Levi, Michael Lawson, Benita L McVicker
In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective Population Database? International journal of molecular sciences 24 (8) (2023)
Martin Tobi, Martin H Bluth, Noreen F Rossi, Ereny Demian, Harvinder Talwar, Yosef Y Tobi, Paula Sochacki, Edi Levi, Michael Lawson, Benita L McVicker
In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective Population Database? International journal of molecular sciences 24 (8) (2023)
Martin Tobi, Martin H Bluth, Noreen F Rossi, Ereny Demian, Harvinder Talwar, Yosef Y Tobi, Paula Sochacki, Edi Levi, Michael Lawson, Benita L McVicker
In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective Population Database? International journal of molecular sciences 24 (8) (2023)
Martin Tobi, Fadi Antaki, Mary Ann Rambus, Yu-Xiao Yang, David E Kaplan, Rebecca Rodriguez, Benedict Maliakkal, Adhip Majumdar, Ereny Demian, Yosef Y Tobi, Paula Sochacki, Murray Ehrinpreis, Michael G Lawson, Benita L McVicker
The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995-2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9. International journal of molecular sciences 24 (24) (2023)
Martin Tobi, Martin H Bluth, Noreen F Rossi, Ereny Demian, Harvinder Talwar, Yosef Y Tobi, Paula Sochacki, Edi Levi, Michael Lawson, Benita L McVicker
In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective Population Database? International journal of molecular sciences 24 (8) (2023)
Martin Tobi, Fadi Antaki, Mary Ann Rambus, Yu-Xiao Yang, David E Kaplan, Rebecca Rodriguez, Benedict Maliakkal, Adhip Majumdar, Ereny Demian, Yosef Y Tobi, Paula Sochacki, Murray Ehrinpreis, Michael G Lawson, Benita L McVicker
The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995-2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9. International journal of molecular sciences 24 (24) (2023)
Martin Tobi, Fadi Antaki, Mary Ann Rambus, Yu-Xiao Yang, David E Kaplan, Rebecca Rodriguez, Benedict Maliakkal, Adhip Majumdar, Ereny Demian, Yosef Y Tobi, Paula Sochacki, Murray Ehrinpreis, Michael G Lawson, Benita L McVicker
The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995-2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9. International journal of molecular sciences 24 (24) (2023)
Kamrine E Poels, Adam J Schoenfeld, Alex Makhnin, Yosef Y Tobi, Yuli Wang, Heidie Frisco-Cabanos, Shaon Chakrabarti, Manli Shi, Chelsi Napoli, Thomas O McDonald, Weiwei Tan, Aaron Hata, Scott L Weinrich, Helena A Yu, Franziska Michor
Author Correction: Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer. Nature communications 13 (1) (2022)
Noura J Choudhury, Alex Makhnin, Yosef Y Tobi, Robert M Daly, Isabel R Preeshagul, Afsheen N Iqbal, Linda S Ahn, Sara A Hayes, Glenn Heller, Mark G Kris, Gregory J Riely, Helena A Yu
Pilot Study of Dacomitinib for Patients With Metastatic EGFR-Mutant Lung Cancers With Disease Progression After Initial Treatment With Osimertinib. JCO precision oncology 5 (2021)
Kamrine E Poels, Adam J Schoenfeld, Alex Makhnin, Yosef Y Tobi, Yuli Wang, Heidie Frisco-Cabanos, Shaon Chakrabarti, Manli Shi, Chelsi Napoli, Thomas O McDonald, Weiwei Tan, Aaron Hata, Scott L Weinrich, Helena A Yu, Franziska Michor
Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer. Nature communications 12 (1) (2021)